AEON vs BA · P/E 0.0, $8.6M cap vs P/E 89, rev $89.46B
AEON Biopharma, Inc. (AEON) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
AEON does not have a complete income-statement cache yet.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the AEON and BA stock pages for the full models.
Not investment advice.